INDEX TO POSTGRADUATE VOLUME 100 MEDICINE JULY-DECEMBER 1996 SUBJECTS ACQUIRED IMMUNODEFICIENCY e Urticaria, diagnosis and treat- ° rey during Penge, di- SYNDROME: See AIDS ment. 100(2):77* agnosis and treatment. 100(4):131* Ag computer- AGING ANAPHYLAXIS CANCER: SeeN i phile.(( 0000)0 06 ):25 © Delirium, recognition, evalua- © Recognition and treatment, pre- CARDIOVASCULAR * High-tech presentations. (DD) tion, and treatment. 100(1):121* venting potentially fatal attacks. ¢ Angina, unstable, _ 100(4):31 © Depression in late life, insights 100(2):87 and treatment. 100(2):13: ¢ Learning and —_ current into diagnosis and consequences. ANEMIA e Angioedema, Teanaeis and using tthhee Web. (DD)1 3):31 100(4):143* e lron deficiency, iron replace- treatment. 100(2):82 ¢ Readers’ questions and com- * Depression in late life, special ment therapy, orally or parenter- e Antihypertensive drug therapy, ments. (DD) 100(5):35 — considerations. 100(4): ally. (CR) 100(5):181 sooaan! appropriate agents. ¢ Tips for browsing the World 161* ANGINA PECTORIS: See Cardio- ‘4):89" Wide Web. (DD) 1 _ ):35 e Elder abuse, recognition and vascular diseases * Chest pain, distinguishing car- Videoconferencing systemsfo r intervention. 100(1):106 ANXIETY diac from noncardiac causes, “telemedicine.” (OD)1 00(1):33 © Hyperlipidemia in elderly, thera- © Relationship to depressive ill- + ae and treatment. 100(6): CONTRAST MEDIA py. 100(1):145 ness, differential diagnosis, treat- © Radiocontrast nephropathy, risk e Hypertension, recent findings ment. 100(2):163* ° _ shock in patients factors, evaluation, and treat- of treatment studies. 100(4):63 APPETITE DISORDERS with hypovolemia, guidelines for . 100(6):88 ¢ Increased risk of postoperative ¢ Malnutrition in elderly, diagno- fluid resuscitation. 100(3):248 COST-BENEFIT ANALYSIS pulmonary complications. 100(5): sis, nutritional replacement thera- ¢ Coronary heart disease in * Clinical practice guidelines to 243 py. 100(1):207* women, gender differences in improve decision making and © Malnutrition in elderly, diagnosis, ARTHRITIS: See Rheumatic dis- presentation and mana ier keep costs down. (ED) 1 ):17 nutritional replacement therapy. eases 100(1):207* ASTHMA ¢ Hypercholesterolemia, guide- DELIVERY OF HEALTHCARE ¢ Renal disorders in older people, © Reflux-related, diagnosis and lines for screening and treatment. © Addressing crisis oh oooh1 8 safety tips on drug choices and treatment. 100(5):106 100(1):138* infectious diseases. (E 21 = 1 ¢ Risk factor for postoperative © Hypertension. (PN) 100(4):84 * Clinical eerey complications. 100(5): © Hypertension, effects of smok- gines for improvement. (ED) *° i nfectious myositis inHI V-positive ing. 100(5):147* 100(3):15 ¢ Treatment, preventive strate- ¢ Hypertension in women and ¢ Measures of fa yea gies. 100(2):105° the elderly, recent findings of formance—HE S teat lan treatment studies. 100(4):58* Employer Data and Information e Anaphylaxis, recognition and BACK e Hypertension, preventing or Set) and the NCQA (National treatment, preventing potentially @ Pain. (PN) 100;6):192 slowing progression of end-stage Commitfotr eQuaelit y Assurance). fatal attacks. 100(2):87* ¢ Pain, SS, for efficient renal disease. 100(5):164 (ED) 100(6):11 ALCOHOLISM evaluation. 100(6):143 ¢ Hypertension, recommended DEPRESSION ¢ In women, importance of early BEHAVIOR DISORDERS lifestyle modifications. 100(4):75* © Clues in primary care practice, detection and treatment. 100(4): e Attention-deficit hyperactivity © Hypertension, resistant,s impli- -_ and treatment. 100(1): 221* disorder. (PN) 100(3):338 fied approach to workup. 100(4): ¢ Preventive, public health ap- * Attention-deficit hyperactivity 97* e In peters with fibromyalgia. proach. 100(1):69° disorder in adults, identification. * Link to cholesterol abnormali- 100(1):159 ALLERGY 100(3):207* ties, advances in treatment. 100(5): In the elderly, insights into e Anaphylaxis, recognition and BEHAVIORAL MEDICINE 61* nosis and consequences. 00K: treatment, preventing potentially ¢ Interventions for insomnia. © Mitral valve prolapse. (PN) 100(1): fatal attacks. 100(2):87* 100(5):198 284 e¢ Asthma, ——. preventive ¢ Psychosocial intervention for de- ¢ Tachycardias, wide-complex, strategies. 100(2):105 pression in the elderly. 100(4):161 - ifying the mechanism. 100(3): information. (PN) 100(1): * Rhinitis, allergic and nonal BLEEDING: See Hemorrhage 99 determining cause and prc ae BLOOD CHEMOTHERAPY: See Drugs, anti- © Relationship to anxiety, differ- appropriate therapy. 100(2):64* ° ge aaeaeeaae diag- neoplastic —_ diagnosis, treatment. 100(2): . os in eyelid dermatitis. 100(2): nosis. 100(1):22 CHILD ABUSE 231 BLOOD La © identification and intervention. DERMATITIS © Treatment, preventive strategies. ¢ Control in patients with renal 100(1):103 ¢ Plant, causes, treatment and 100(2):87* impairment slows a of prevention strategies. 100(3):159* ¢ Treatment with immuno’ renal disease. 100(5):1 * Abnormalities, advances in —— contraindications. BREAST DISEASES treatment to reduce incidence of ¢ End-stage renal disease, pre- 100(2):12: ¢ Cancer, screening and evalua- cardiovascular events. 100(5):61* ventive measures. 100(5):163 tion. (GL) 100(3):180 © Hypercholesterolemia, risk fac- TECHNIQUES tor in coronary artery disease, ¢ Colonoscopy, bowel prepara- *Major clinical discussion CALCIUM guidelines for screening and mended methods CR, Case © Hypercaicemia, mechanisms, treatment. 100(1):138* CV, Clinical Viewpoint diagnosis, and remedies. 100(6): COLONIC DISEASES: angina. ital Doc 119° intestinal diseases CALCULI COLONOSCOPY e Invasive, for Helicobacter py- GL, Clinical Practice Guidelines e Renal, evaluation and treat- p° ln onp reparation, four recom- lori infection. 100(5):123 PH, Physician-at- ment, prevention of new stone mended methods of colon lavage. ¢ Noninvasive, 10085H)el1i cobacter PN: Patient Notes formation. 100(6):63* 100(2):203* pylori infection.1 5):1 continued VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE ARRR NE TER, INDEX TO VOLUME 100 CONTINUED ¢ Patch testing for eyelid derma- © For fibromyalgia. 100(1):166 e Esophageal causes of chest titis. 100(2):233 ¢ For patients with depression pain. 100(6):107 ¢ Preoperative pulmonary func- accompanied by symptoms of for gastroesophageal reflux dis- * Gastroesophageal reflux dis- tion tests to identify patients at anxiety. 100(2):172 ease. 100(5):80 ease, common — ions and risk for postoperative pulmonary DRUGS, ANTIHISTAMINE DRUGS, PSYCHOTROPIC treatment options. 100(5):95* ¢ For treatment of allergic rhinitis. © For delirium. 100(1):133 ° Gastroesophageal reflux dis- 100(2):67 DRUGS, SIDE EFFECTS ease, current options for short- DRUGS, ANTIHYPERTENSIVE * From endocrine for ad- - long-term treatment. 100(5): ¢ Choosing a agents, vanced prostate cancer. 1 (3):146 study findings. 100(4):89* e Upper goo tract, © Hepatitis: See Hepatitis * Special considerationsi n treat- from NSAI ):131* ° anne — fluid to interpret results. 100(1): 173° ment of women and the elderly. management. 100(3):243 DIARRHEA 100(4):68 EAR DISEASES * Peptic ulcer disease complicat- ¢ Traveler's, prevention. 100(6): DRUGS, ANTI-INFLAMMATORY * Pathologic conditions of exter- ed by Helicobacter pylori infec- 165 . hace canes 100(2): nal ear and auditory canal, guide- tion, diagnosis and treatment. DIET: See Nutrition 11 lines for identification and treat- 100(5):115* DIZZINESS ment. 100(3):223* a effects of NSAIDs. 100(5): ¢ Patient information. (PN) 100(4): ¢ Chemotherapfyo r active tuber- 131* 248 —_ bea na e In di nosis of unstable angi- © Traveler's diarrhea, prevention. DOMESTIC VIOLENCE can- na. 1 14 100(6):165 ® Recognition and comprehen- cer. 100(2):217 ELDERLY: See Aging GENITAL DISEASES sive . 100(1):103* ELECTROCARDIOGRAPHY ¢ Paraphimosis, evaluation and DRUG THERAPY e Interferon in treatment of © In diagnosis of unstable angi- treatment. 100(4):188 ¢ Antihypertensive, choosing chronic viral hepatitis, current na. 100(2):142 ¢ Testicular torsion, diagnosis late agents. 100(4):89* ions. 100(3):55” e In ———— of wide-complex and t . 100(4):189 ° bination, for Helicobacter ¢ Interferon therapey d chronic tachycardias. 100(3):265 * Uterine prolapse, indication for pylori infection. 100(5):123 viral hepatitis. 100(3) EMERGENCY hysterectomy. 100(6):136 e For gastroesophageal reflux DRUGS,A ¢ Urologic emergencies, over- GERIATRICS: See Aging disease, options for short- and NODE BLOCKER view of conditions affecting kid- CLINICAL pica treatment. 100(5):79 ¢ For wide-complex tachycardia, ney, ureter, bladder, le, and * Breast cancer, screening and restart TOOT eee when to administer. 100(3):272 urethra. 100(4):177* evaluation. (GL) 100(3):180 00(1):1 DRUGS, BRONCHODILATOR ¢ Urologic emergencies, trauma ¢ Pediatric immunization. (GL) p. y myo eens choice of agents — 100(2): injuries and of con- 100(5):213 and effects. 100(5):202 1 ditions affecting penis, scrotum, GYNECOLOGY: See Obstetrics/ * For kidney diseases in the el- DRUGS, CORTICOSTEROID and testicles. 100(4):187* Gynecology derly, considering age-related ¢ For treatment of allergic rhinitis. ENDOCRINE DISORDERS (6):44 100(2):69 © Hypercaicemia, mechanisms, HEARING DISORDERS * For nephrolithiasis. 100(6):71 ¢ For treatment of severe asthma —_— and remedies. 100(6): ¢ Loss, clues to pathologic con- ¢ For treatin —_—, in flare-ups. 100(2):118 119° ditions of auditory canal, diagno- smokers. 100(5):1 DRUGS, HISTAMINE ENDOSCOPY sis and treatment. 100(3):223 * For unstable angina. 100(2):149 ANTAGONIST © In detecting juodenal u!- HEART DISEASE: See Cardiovas- © Interferon for chronic viral hep- e For gastroesophageal reflux cers in patients taking NSAIDs. cular diseases atitis. 100(3):68 disease. 100(5):79 100(5):136 HEMATOLOGIC DISEASES © Interferon for chronic viral hep- ENVIRONMENTAL HAZARDS ¢ Associated with parvovirus B19 atitis, limited use. 100(3):55* — air pollution. (PN) 100(2): infection. 100(1):239 DRUGS, ADVERSE REACTION HEMORRHAGE © Drug-induced lupus, case reiat- ¢ Low-frequency magnetic fields, * Distinguishing between ed to quinidine. (CR) 100(3):299 role in etiology of cancer, current —_ and hematemesis. 100(1): ¢ Drug-induced nephrotoxicity, issues. 100(2):183* high-risk situations, prevention of EXERCISE HEPATITIS renal damage. 100(6):83* for prostate cancer. 100(3):112 ¢ Role in treatment of fibromyal- ¢ A, vaccine, overview and rec- DRUGS, ANALGESIC DRUGS, HYPNOTIC gia. 100(1):166 ommendations for use. 100(4):117 © For treatment of chronic pain. * For treatment of insomnia, * To prevent or control hyperten- © Viral, chronic, interferon thera- 100(3):283 choice of agents and effects. sion. 100(4):77 py. 100(3):68 : DRUGS, 100(5):202 EYE DISORDERS * Viral, chronic, use of interferon ENZYME (ACE) INHIBITOR DRUGS, LEUKOTRIENE INHIBITOR © Eyelid dermatitis, causes, diag- in treatment. 100(3):55* ® Beneficial effects in diabetic e In dev it for treatment of nosis, and treatment. 100(2):231* HORMONES asthma. 100(2):112 ¢ Endocrine ¢ Risk for acute renal failure. DRUGS, LIPID-LOWERING FEVER 100(6):99 ¢ HMG-CoA reductase inhibitors, © Typhoid, vaccine, overview and ¢ Hormone replacement therapy DRUGS, ANTIARRHYTHMIC pharmacologic actions, anatomic recom i for use. 100(4): for eee women with ¢ For patients with ventricular effects, and effects on mortality. 121 coronary heart disease. 100(3):195 tachycardia. 100(3):272 100(5):61* FIBROMYALGIA HYPERTENSION: See Cardiovas- DRUGS, ANTIBIOTIC DRUGS, — and treatment. 100(1): cular diseases * Aminoglycosides, risk of neph- ANTI-INFLAMMATORY (NSAIDs) HYPOVOLEMIA rotoxicity. 100(6):94 — chronic pain relief. 100(3): FLUID THERAPY e Emergency fluid management. ¢ Chemoprophylaxis, postsple- * Oral rehydration therapy for hy- 100(3):243* nectomy infection. 100(1):198 ne effects. 100(5): povolemia. 100(3):244 © For treatment of bacterial pyo- 131° FOOT DISORDERS IMMUNIZATION dermas in adults, common regi- — information. (PN) 100(5): ¢ Gout, unusual presentations, ¢ New and improved vaccines, mens. 100(3):313 tips for accurate diagnosis. (CR) most le use. 100(4):113* © Resistance, public health threat. ¢ Risk for renal dysfunction or 100(1):253 ¢ Pediatric, recommendations. (ED) 100(5):15 nephrotoxicity. 100(6):97 (GL) 100(5):213 DRUGS, ANTIDEPRESSANT OPIOID GASTROINTESTINAL DISEASES ¢ Pneu vaccine to pre- ¢ For depression. 100(11)) :93 ¢ For chronic pain management. * Bowel preparation before vent postsplenectomy infection. © For depression in the elderly, 100(3):283 colonoscopy, four recommended 100(1):198 special considerations. 100(4):162 — of colon lavage. 100(2): ¢ Requirements for international travel. 100(6):159 VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE IMMUNOTHERAPY e Renal colic, diagnosis and NEOPLASMS ¢ Pathologic conditions of exter- ¢ For treatment of allergy, indica- treatment. 100(4):11 77 * Adnexal masses, indication for nal ear and audit , identi- tions, contraindications. 100(2): KNEE INJURIES hysterectomy. 100(6):136 fication and treatment. 100(3): 123* ¢ Patellar tendon rupture, timely ¢ Bladder cancer, diagnosis and IMPOTENCE recognition and management. treatment. 100(2):217* ¢ Complication after radical (CR) 100(2):241 ¢ Breast cancer, screening and PAIN prostatectomy. 100(3):129 evaluation. (GL) 100(3):180 © Chest, noncardiac, causes, di INCONTINENCE LABORATORY INVESTIGATION e Cancer, possible cause of low nosis, and treatment. 100(6):10 ¢ Complication after radical pros- * Prostate-specific antigen (PSA) back pain. 100(6):146 ¢ Chronic, effective pharmaco- testing for prostate cancer, key © Cancer, role of low-frequency management. 100(3):281* considerations. 100(3):90* —- fields in etiology. 100(2): ¢ Fibromyalgia, diagnosis and treatment. 100(6):137 ¢ Tuberculin skin testing, inter- 183° treatment. 1s Oai153 INFANTS pretation of results. 100(4):202 e External ear, diagnosis and © Low back. (PN) 10000(64) :192 ¢ Effects of maternal drinking. e Urinalysis, knowing when to or- t 00(3):228 ¢ Low back, pnb for effi- 100(4):224 der and interpreting results. ¢ Malignancy, cause of hypercal- cient evaluation. 100(6):143* INFECTION 100(1):173* cemia, diagnosis and treatment. © Pelvic, indication for hysterec- ¢ Bacterial pyodermas, recogni- LIVER DISEASES 100(6):119 tomy. 100(6):135 tion and treatment. 100(3):311* ¢ Chronic viral hepatitis, interfer- ¢ Prostate cancer, advanced PATIENT COMPLIANCE ° a of new diseases, on therapy. 100(3):68 a key points in man- * Noncompliance with treatment, scope of problem. (ED) 100(5):15 ¢ Chronic viral hepatitis, use of agement. t 21 factor in resistant hypertension. © Helicobacter pylori, in patients interferon in treatment. 100(3):55* ¢ Prostate cancer, follow-up after 100(4):98 with gastric disease, diagnosis LUNG DISEASES therapy. 100(3):125* PATIENT EDUCATION and treatment. 100(5):115* e Marked by hemoptysis, evalua- * Prostate cancer, localized, ¢ Attention-deficit hyperactivity ¢ Infectious myositis, increasing tion and management. 100(1):227* it options, pros and cons. . (PN)1 ¥3 38 incidence, — and treat- LUPUS ERYTHEMATOSUS, 100(3):105* —— 99 ment. 100(2):193 SYSTEMIC © Prostate cancer screening, key ¢ Parvovirus ee , associated ¢ Drug-induced, case related to considerations. 100(3):90* diseases. 100(1): use of quinidine. (CR) 100(3):299 NEUROLOGIC MANIFEST. * Pelvic, chronic, aaa erec- e Attention-deficit hyperactivity tomy in treatment. 100(6):137 MALARIA disorder in adults, identification. e Risk after splenectomy, treat- ¢ Prevention in internationai trav- 100(3):207* ment strategies. 100(1):195* elers. 100(6):169 © Dizziness. (PN) 100(4):248 ¢ Travel-related, immunizations MALPRACTICE © Neurodeficit disordersa s 1001)-284v alve prolapse. 82 and other preventive strategies, ¢ National Practitioner Data Bank of low back = 100(6):149 a for information. 100(6): (NPDB), intended use, economic e Pain: See Pain © Nonsteroidal anti-inflammatory 159° issues. (ED) 100(1):15 NUTRITION drugs (NSAIDs). (PN) 100(5):266 ¢ Tuberculosis, recommenda- MEDICAL PRACTICE © Dietary adjustments to prevent ¢ Smoking cessation to reduce tions for screening, prevention, ® Clinical practice guidelines as or control hypertension. 100(4):75 cardiovascular of nicotine. and treatment. 100(4):201* engines for improvement. (ED) * Dietary modifications to slow 100(5):147* e Urinary tract, current cost- 100(3):15 progression of renal disease. © Strategy for preventing post- effective management strategies. ¢ Improving decision-making 5):174 splenectomy infection. 10001):201 100(5):229* process with clinical practice ¢ Iron replacement therapy, oral PEDIATRICS INFLAMMATION guidelines. (ED) 100(2):17 or parenteral, for iron deficiency © Child abuse, identification and Eyelid dermatitis, causes, diag- ¢ Measures of professional per- anemia. (CR) 100(5):181 intervention. 100(1):103 nosis, and treatments. 100(2): 231* formance—HEDIS (Health Plan * Mainutrition in elderly, —_ ¢ Hypovolemia in infants and e Gout, unusual presentations, Employer Data and Information sis, nutritional children, be fluid man- tips for accurate diagnosis. (CR) Set) and the NCQA (National py. 100(1):207* % : 100(1):253 Committee for Quality Assurance). ¢ Immunization recommenda- INJURIES: See Trauma (ED) 100(6):11 OBESITY tions. (GL) 100(5):213 INSOMNIA ¢ National Practitioner Data Bank * Increased risk of postoperative ¢ Varicella virus vaccine, over- ¢ Causative factors, behavioral (NPDB), intended use, economic pneumonia. 100(5):243 view and recommendations for and therapy. 10065): issues. (ED) 100(1):15 e Weight reduction to reduce use. 100(4):113 195" © Preserving personal and pro- blood pressure. 100(4):76 PHYSICIANS INTERFERON fessional mentoring in medicine. ¢ Helpful and interesting World + chronic viral hepatitis. 100(3): (ED) 100(4):15 ¢ Hysterectomy for benign gyne- Wide Web sites. (DD) 1 ):35 ¢ Readers’ questions ard com- cologic disorders, overview of ¢ Learning opportunities on the e In treatment of chronic viral ments on using computers in prac- when and why. 100(6):133* Web. (DD) 100(3):31 hepatitis, current considerations. tice. (DD) 100(5):35 ° , effects on coronary © Mentoring, i 100(3):55* e Videoconferencing, the emerg- heart disease in women. 100(3): tion along with satisfac- IRON ~. market for “telemedicine.” 191* tion. (ED) 100(4):15 © Deficiency anemia, oral or par- (DD) ) 100(1):33 * Urinary caiculi during preg- e Using tech in - enteral iron replacement therapy. METABOLIC nancy, diagnosis and treatment. tions. (90) 100(4) 1 (CR) 100(5):181 © Hypercalcemia, mechanisms, 100(4):131* PLANTS diagnosis, and remedies. 100(6): OCCUPATIONAL DISEASES ¢ Cause of dermatitis, possible KIDNEY DISEASES 119° ¢ Exposure to Mycobacterium causes, treatment and i ¢ End-stage renal disease, mea- ‘AL DISORDERS tuberculosis, routine screening. strategies. 100(3):159* sures to prevent it or slow pro- e Fibromyalgia, diagnosis and 100(4):217 POLLUTION gression. 100(5):163* °153* © Role of low-frequency magnet- © Indoor air. (PN) 100(2):252 * Hypovolemia, em e Infectious myositis, increasing ic fields in cancer. 100(2):183 PREGNANCY: See Obstetrics/Gy- 00( incidence, diagnosis and treat- OCULAR DISORDERS: See Eye ment. 100(2):193* isorders PREVENTIVE MEDICINE © Low back pain. (PN) 100(6):192 e Alcoholism, public health ap- ¢ Nephrolithiasis, ‘evaluation and ¢ Low back pain, guidelines for proach combining medical, psy- treatment, prevention of new efficient evaluation. 100(6):143* chological, and social interven- stone formation. 100(6):63* ¢ Pateliar tendon rupture, timely tions. 100(1):69* * Nephrotoxicity, drug-induced, recognition and management. ¢ Immunization and other strate- high-risk situations, prevention of (CR) 100(2):241 i¢s to prevent travel-related in- renal damage. 100(6):83* = teak1 00(6):159* VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE TO VOLUME 100 CONTINUED * Lifestyle modifications to pre- * Low-frequency magnetic fields SHOCK TRAUMA v1e0n0(t4 ):o7r5 * control hypertension. e183° ee 100(2): * Circulatory, in patiewnitth shy - t¢ racAtc,u teev ailnujautriyo no f agnedn itmoaunriangaer-y ¢ Measures to prevent infection * Tuberculosis, recommendations ment. 100(4):194 in patients after splenectomy. for screenin , prevention, and ¢ Indication for splenectomy, 100(1):198 treatn 1 (4):201* * Cancer, manifested by neo- treatment strategi ~ = reduce © Pediatric immunization. (GL) * Vaccines, new and improved, plasmsof external ear. 100(3):228 risko f infection. 1 10085. 213 most appropriate use. — 113° ¢ Common skin infections, recog- © Patellar tendon = timely * Preventing end- renal dis- PULMONARY DISEASES: See Lung nition and treatment. Faces «gg hl recognition and management. ease in patients with les and diseases: ¢ Eyelid dermatitis, diag- (CR) 100(2):241 —— 100G5):163 nos, and treatments, 110000(2() :231* TRAVEL Preventive therapy for tubercu- QUAOLF IHEATLTHYCAR E ¢ Plant dermatitis, causes, treat- e Infectious disease, immuniza- losis in high-risk groups. 100(4): ® Clinical improvements with use ment and prevention strategies. tions and other preventive strate- 202 ¢ practice guidelines. (ED) 100(3): 100(3):159* gies for travel-related infections. ¢ Vaccines, new and improved, ¢ Urticaria, — and treat- 100(6):159* most appropriate use. 100(4):113* ¢ Improving decision-making ment. 100(2):77* TUBERCULOSIS PROSTATIC DISEASES process with clinical practice SLEEP DISORDERS e Recommendations for screen- ¢ Advanced (metastatic) prostate guidelines. (ED} 100(2): ¢ In patients with fibromyalgia. ing, prevention, and treatment. cancer, key points in manage- ¢ Measures of professional - 100(1):159 (4):201* ment. 100(3):139" formance HEDIS (Health Pian ¢ Insomnia, causative factors, See Neoplasms © Cancer, follow-up after therapy. Employer Data and Information behavioral and pharmacologic 100(3):125°* Set) and the NCQA (National therapy. 100(5):195 ULCER ¢ Cancer, localized, treatment Committee for Quality Assur- SMOKING ¢ Peptic, complicated by Heli- = pros and cons. 100(3): ance). (ED) 100(6):11 © Effects on cardiovascular sys- cobacter pylori infection, diagno- 105° ¢ National Practitioner Data Bank term. 100(5):147* sis and treatment. 100(5):115* * Cancer, screening, key consid- (NPDB), intended use, economic * Increases risk for postoperative ® Side effoef NcSAtIDs . 100(5):132 erations. 100(3):90° issues. (ED) 100(1):15 — complications. 100(5): TRACT DISORDERS ¢ Prostatitis and prostatic ab- 1 * Infection, current cost-effective scess, diagnosis and treatment. RADIOGRAPHY SOCIAL PROBLEMS ——— strategies. 100(5): 100(4):180 ¢ Nephrotoxicity induced by con- ¢ Domestic violence, compre- PSYCHIATRIC/PSYCHOSOCIAL trast media. 100(6):88 hensive management strategy. © Pyelonephritis and renal ab- DISORDERS RADIOTHERAPY 100(1):103* scess, diagnosis and treatment. e Alcoholism in women, impor- ¢ For organ-confined prostate SPLENIC DISEASES 100(4):178 tance of early detection and treat- cancer. 100(3):111 ¢ Postsplenectomy care to de- UROLOGIC DISEASES ment. 100(4):221° RENAL DISEASES: See Kidney crease risk of infection. 100(1): ¢ Acute urinary retention, diagno- ¢ Alcoholism, co public diseases sis and treatment. 100(4):179 health approach. 100(1):69 RESPIRATORY DISEASES ry man ny ¢ Bladder cancer, diagnosis and ¢ Anxiety and depressive disor- Asthma, treatment, preventive ¢ Recognition and management. treatment. 100(2):217* ders, i strategies. 100(2):105* 100(1):104 e Emergencies, management of * Chronic cough, extraesophageal STRESS trauma injuries and conditions af- e Attention-deficit hyperactivity mpinaiation ¢ Physiologic responses, role in fecting penis, scrotum, and testi- disorder. (PN) 100(3):338 reflux disease. 100(5):106 fibromyalgia. 100(1):153 cles. 100(4):187* © Attention-deficit hyperactivity j° oe by hemoptysis, evalua- SUICIDE e Emergencies, overview of con- disorder in adults, identification. and management. 100(1):227* ¢ Consequence of untreated de- ditions affecting kidney, ureter, 100(3):07° p° y ee complications from pression in the eiderly. 100(4):50 bladder, prostate, and urethra. * Delirium, recognition, evalua- surgery, preoperative evaluation ¢ Risk in patients with depres- 100(4):177* ton,a nd treatment. 100(1):121* to identify patients at increased sion. 100(1):88 © End-stage renal disease, mea- * Depression. (PN) 100(1):99 risk. 100(5):241* SURGERY sures to prevent it or slow pro- and affective disor- ¢ Rhinitis, allergic and nonaller- ¢ Antireflux for long-term control gression. 100(5):163* on in patients with fibromyaigia. gic, determining cause and of gastroesophageal reflux dis- © Fournier’s rene, evaluation 1OOtty: 159 pees appropriate therapy. ease. 100(5):89 and treatment. 100(4):193 © Depression in late life, insights 100(2):64 ¢ Hysterectomy for benign gyne- ¢ Nephrolithiasis, evaluation and into diagnosiasn d consequences. ¢ Tuberculosis, recommenda- cologic disorders, overview of treatment. prevention of new 100(4):143* tions for screening, prevention, when and why. 100(6):133* stone formation. 100(6):63* © Depression in late life, special and treatment. 100(4):201* © Preoperative pulmonary evalu- * Nephrotoxicity, drug-induced, — considerations. 100(4): RHEUMATIC DISEASES ation, identifying patients at risk Ss, prevention of ¢ Fibromyalgia, oo and for complications. 100(5):241* * Depression, manifestations, di- treatment. 100(1):153* ¢ Prostate, for cancer, surgical ¢ Periurethral abscess, diagnosis and treatment. 100(1):85* ¢ Gout, unusual presentations, options. 100(3):107 and treatment. 100(4):183 ¢ Domestic violence, compre- tips for cre, diagnosis. (CR) omy, postsurgical care ¢ Prostate cancer, advanced hensive t. 100(1):103* 100(1):253 a decrease risk of infection. (metastatic), key points in man- * Insomnia, causative factors, © Systemic lupus losus, 100(1):195* 00(3):139* behavioral and pharmacologic drug-induced, case related to therapy. 100(5):195* quinidine. (CR) 100(3):299 THERAPEUTICS © Role in patients with noncar- © Immunotherapy for allergic sen- ¢ Prostate cancer, localized, diac chest pain. 100(6):108 SCREENING sitivities, indications, contraindica- py te tenes 100(3):105* PUBLIC HEALTH * Cholesterol, risk factforo cror o- tions. 100(2):123* e cancer, screening, key ¢ Alcoholism, public health ap- + Porb oastc ane1 00(1):138 ¢ Investigational therapies for considerations. 100(3):90* proach in education, prevention, Ang breast cancer. (GL) 100(3): prostate cancer. 100(3):112 * Renal disorders in the elderly, and intervention. 100(1):69* * |ron replacement therapy, oral safety tips on drug choices and * Community resources for vic- °y * tuberculosis, recommenda- or parenteral, for iron deficiency doses. 100(6):44 tims of domestic violence. 100(1): tions for screening, prevention, anemia. (CR) 100(5):181 © Stress incontinence in women, 114 ¢ Percutaneous transluminal role of hysterectomy in treatment. a° infectious diseases, coronary —— ty for unstable 100(6):137 problem. (ED) 100(5):15 ations. 100(3):90* angina. 100(2):153 e Urethral stricture, evaluation = Indoora ir pollution. (PN) 100(2): SEXUAL DISORDERS TOBACCO and management. 100(4):183 ¢ Impotence following radical * Nicotine’s effects on cardiovas- © Urinary calculi pregnancy, ——s treatment. 100(3): cular system. 100(5):147* or and treatment. 100(4): 1 131° VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE VACCINATION: See Immunization ¢ Parvovirus B19 infection, as- WOMEN ¢ Hypertension, recent findings VERTIGO sociated diseases. 100(1):239* ¢ Alcoholism, increasing inci- of treatment studies. 100(4):60 ¢ Patient information. (PN) 100(4): dence, importance of early de- ° eS age er for benign gy- V4I8R AL DISEASES We ATDEisRt-uErLbEaCnTcReOsL YiTnE elBdeArLlAy NCpEa - =1° and treatment. 100(4): disorders, overview of ¢ Hepatitis, chronic, interferon tients, age-related changes in © Gender differences in presen- therapy. 190(3):68 kidney function. 100(6):44* tation and of coro- nary * Hepatitis, chronic, use of inter- nary heart disease, effects of ment. 100(4):131* feron in treatment. 100(3):55* menopause. 100(3):191* WOUNDS/INJURIES: See Trauma AUTHORS AIMI G BREEN KJ FREEDMAN A See Crosignani PG See El-Mallakh RS Follow-up after therapy for ALIH prostate cancer: Treating the Introduction to symposium on CARROLL JA problems and caring for the man. — renal problems. 100(6): Common bacterial pyodermas: 100(3):125 Taking aim oaks — most likely FRIERSON RL Renal disease in the elderly: pathogens. 100(3): See Biondell RD Distinctive disorders, tailored CASEY DA treatments. 109(6):44 Delirium: Quick recognition, GANDHI S AMIDON TM careful evaluation, and appropri- Resistant hypertension: Sug- 4 reasons Introduction to symposium on ate treatment. 100(1):121 gestions for dealing with the to help your patients kick the hypertension. 100(4):53 CLARK CL it. 100(6):147 Complications of gastro- KORETZR L esophageal reflux disease: Chronic viral and use A new malpractice defense: Esophagitis, acid laryngitis, and of interferon: Whom are we Common sense. (PH) 100(1):29 beyond. 100(5):95 treating? 100(3):55 To sigh for: Diseases that don’t COLICE GL make our day. (PH) 100(5):31 Hemoptysis: Three quesiions RR Top 10 easy eats: A physician's that can direct management. the gray zone: How bread and butter. (PH) 100(4):27 100(1):227 Allergic and nonallergic rhinitis: clinical practice guidelines can CONNELLY C Directing medical therapy at spe- improve the decision-making pro- BADALAMENT RA Easing low back pain. (PN) cific symptoms. 100(2):64 cess. (ED) 100(2):17 Bladder cancer: Current diag- 100(6):192 introduction toa n on LAVENDER RC nostic methods and treatment Patients with low back pain: allergy. 100(2):59 See Mohr DN options. 100(2):217 How to identify the few who need LEVINE RJ BAQUIS G extra attention. 100(6):143 HAHN G Patellar tendon rupture: The im- See O’Neill DS CONRAD DA See Freedman A portance of timely recognition New and improved vaccines: HOOD VL and repair. (CR) 100(2):241 Promising weapons against vari- End-stage renal disease: Mea- LIPPMANN SS cella, hepatitis A, and typhoid sures to prevent it or slow its pro- Introductiont o Options in antihypertensive fever. 100(4):113 gression. 100(5):163 drug therapy: Help in choosing CROSIGNANI HORWITZ B See also Blondell RD; Casey DA; from among the many agents. i gyne- See Clark CL El-Mallakh RS; Pary R: Steiner RP cologic disorders: When and HOUSHIARA M LOVE N why? 100(6):133 Urinary calculi pregnan- Forgotten men? epeeeton cy: When are caufsor econ - comi . 100(3): cern? 100(4):131 See also Freedman A; Luttge S; HOWARDR B Taub M; Williams TR Life at Windy Acres. (PH) 100(3):21 LUTTGE S$ Screfore pronstatie cnancegr: I si t j other INSTIFOTR UCLTINIECA L a service or a disservice? 100(3):90 preventive strategies. 100(6):159 Hypercalcemia: Mechanisms, SYSTEMS INTEGRATION BLAKE-INADA LM differential diagnosis, and reme- Breast cancer screening and Unstable angina: Strategies to dies. 100(6):119 evaluation. (GL) 100(3):180 minimize myocardial injury. DMOCHOWSKI RR Pediatric immunization. (GL) 100(2):139 See Samm BJ 100(5):213 Noncardiac chest pain: Where BLONDELL RD does it start? 100/6):107 Alcoholism: Taking a preventive, EL-MALLAKHRS JANEIRA LF MISDOPAJI J public health approach. 100(1):69 Clues to depression in primary Wide-complex tachycardias: Urinalysis: When—and when BONAGURA AF care practice. 100(1):85 The i of i the not—to order. 100(1):173 Helicobacter pylori infection: ERCOLEC J mechanism. 100(3):259 MOFFITT MP The importance of eradication in See Houshiar AM JENSENH B Tuberculosis: Recommendations patients with gastric disease. See Conrad DA for screening, prevention, and 100(5):115 FEDERMAND G JUCKETT G treatment. 1004-201 BRADY WM ae lives. (PH) 100(6):19 Plant dermatitis: Possible cul- Gastroesophageal reflux dis- FEIFEL prits go far beyond poison ivy. Preoperative pulmonary evalu- ease: The long and the short of Attention-deficit hyperactivity 100(3):159 ation: Identifying patients at in- therapeutic options. 100(5):76 disorder. (PN) 100(3):338 creased risk for complications. Attention-deficit hyperactivity KAPLAN B 100(5):241 disorder in adults. 100(3):207 See Swain RA continued VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE WITH EVOLUTION COMES CHANGE. INDEX TO VOLUME 100 CONTINUED MONTGOMERY E O'NEILL DS POTTS JF REINERTSEN JL See Swain RA Infectious myositis: A tropical ‘Dear Digital Doc...’ (DD) 100(5):35 See Mosser G MORAL L disease steals out of its zone. ir REYNOLDS E See O'Neill DS 100(2):193 in women and the MORRIS RJ OSTERHOLM MT elderly: Some puzzling and some Asthma: Specific preventive Emerging infectious diseases: sions of kilobits and gigabytes expected findings of treatment strategies. 100(2):105 A real public health crisis? (ED) dancing through your head? (DD) studies. 100(4):58 MOSSER 100(5):15 100(6):25 RICH MW Healthcare guidelines as en- OSTROWSKI VB Learning on the Web. (DD) Drug-induced lupus: The list of gines for improvement. (ED) Pathologic conditions of the 100(3):31 — — (CR) 100(3):299 100(3):15 ear and auditory canal. Videoconferencing systems: 100(3): 223 ‘Telemedicine’ has arrived. (DD) Ieeoduction to symposium on NESSE RE 100(1):33 peptic acid disease. 100(5):75 Feeling hopeless and helpless: aw ens pee way through the When anxiety symptoms coexist Eyelid dermatitis: A common, of- (DD) 100(2):35 SAADEH C = depressive disorder. 100(2): taen e rash. 100(2):231 See Uy JP 1 QADRI SM SALVATORE JR NGUYEN PL Sesteant of insomnia: Getting See Qari M Low-frequency magnetic fields See Misdraji J to the root of sleeping problems. QARIM and cancer: What you should NORTH CS 100(5):195 Parvovirus B19 infection: Asso- know and what to tell your pa- Alcoholism in women: More PEARSON sP ciated diseases, common and tients. 100(2):183 common—and serious—than you Gastrointestinal effects of uncommon. 100(1):239 SAMM BJ might think. 100(4):221 NSAIDs: Difficulties in detection Urologic emergencies: Condi- NUWAYHID N and management. 100(5):131 RACKLEY CE tions affecting the kidney, ureter, See Uy JP PFLEDERER TA Advances in treatment of bladder, prostate, and urethra. Emergency fluid management cholesterol abnormalities: The 100(4):177 OGOREKC P for hypovolemia. 100(3):243 role of HMG-CoA reductase in- continued See Brady WM hibitors. 100(5):61 VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE INDEX TO VOLUME 100 CONTINUED Urologic emergencies: Trauma STACEY BR TRIVEDI BK WILLIAMST R injuries and conditions affecting Effective management of chronic Nephrolithiasis: How it Treatment of localized prostate the penis, scrotum, and testicles. pain: The analgesic dilemma. and what to do about it. 100(6): 63 cancer: Choosing the best alter- 100(4):187 100(3):281 native. 100(3):105 SANTIESTEBANH STEINER RP Uv JP WISE GR See Gandhi S Domestic violence: Do you know Unusual presentations of gout: Hyperlipidemia: When does treat- SCHERVISHE W when and how to intervene? Tips for accurate diagnosis. (CR) ment make a difference? 100(1): See BadalamentR A 100(1):103 100(1):253 138 SCHOENWETTER wr SUDHIR K WISINGER DB Safe allergen immunotherapy: See Zeliner C VAAMONDE CA Urinary tract infection: Current The correct allergen, the appro- SVEUM RJ See Thatte L priate patient, the adequate dose. Urticaria: The Seapets challenge VANSICKLE K aSee z 100(2):123 of hives. 100(2):77 See Casey DA; Steiner RP WRIGHT JC SCHULTZ TT SWAINR A VERCELLIN! P See El-Mallakh RS See Wise GR lron deficiency anemia: When is See Crosignani PG WYATT R SETNESS PA parenteral therapy warranted? VILLABLANCA AC Anaphylaxis: How to recognize, Anti-inflammatory drugs. (PN) (CR) 100(5):181 Coronary heart disease in treat, and prevent potentially fatal 100(5):266 women: Gender differences and attacks. 100(2):87 Dizziness. (PN) 100(4):248 TAUB M effects of menopause. 100(3):191 a air pollution. (PN) 100(2): Advanced prostate cancer: En- docrine therapies and palliative WEBB WK Major depression. (PN) 100(1):99 measures. 100(3):139 See Pary R simply a matter of not eating Mentoring: Leaving a legacy of THATTE L WIET RJ enough? 100(1):207 opportunity and responsibility. Drug-induced nephrotoxicity: See Ostrowski VB ZELLNER C (ED) 100(4):15 The crucial role of risk factors. WILKE WS Lifestyle modifications for hy- Sizing up our professional per- 100(6):83 Fibromyalgia: Recognizing and pertension: The many benefits formance: Can we use HEDIS as TOBIAS CR addressing the multiple interrelat- are worth the effort. 100(4):75 a springboard to improvement? See Pary R ed factors. 100(1):153 ZISOOK S (ED) 100(6):11 TOOSON JD WILLIAMS BJ Depression in late life: Diagno- What do you know about the Bowel preparation before ‘I need a referral.’ (PH) 100(2):29 sis, course, and consequences. NPDB? (ED) 100(1):15 : Choosing the best WILLIAMS DN 100(4):143 MS lavage regimen. 100(2):203 Postsplenectomy care: Strate- Depression in late life: os gies to decrease the risk of infec- oe in treatment. 100(4): tion. 100(1):195 CHANGE YOUR REGIMEN. © McN/OPC 1996 08K0842J